CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to optimize treatment for schizophrenia by improving existing therapies and exploring new options. It focuses on using advanced imaging techniques and psychosocial interventions to enhance treatment outcomes and reduce medication discontinuation, while investigating novel compounds like cannabidiol.
OPTiMiSE (OPtimization of Treatment and Management of Schizophrenia in Europe) will focus on two goals: optimising current treatments in Schizophrenia and explore novel therapeutic options for schizophrenia.
The project intends to both address basic, but so far unanswered, questions in the treatment of schizophrenia and develop new and experimental interventions.
It is expected that the project will lead to evidence that is directly applicable to treatment guidelines, will explore the developmen…
UNIVERSITAIR MEDISCH CENTRUM UTRECHT
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
United Kingdom, London
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
United Kingdom, Manchester
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
ZENTRALINSTITUT FUER SEELISCHE GESUNDHEIT
Germany, Mannheim
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
